GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Other Income (Expense)

Seoul Pharma Co (XKRX:018680) Other Income (Expense) : ₩369 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Other Income (Expense)?

Seoul Pharma Co's other income expense for the Seoul Pharma Co's pretax income for the three months ended in Mar. 2025 was ₩-4 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩369 Mil.


Seoul Pharma Co Other Income (Expense) Historical Data

The historical data trend for Seoul Pharma Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Other Income (Expense) Chart

Seoul Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,192.24 -2,869.05 -2,059.47 2,889.82 372.90

Seoul Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 20.18 35.22 317.50 -3.67

Seoul Pharma Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩369 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Seoul Pharma Co  (XKRX:018680) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Seoul Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710
Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines